🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#EHA23 Simone Dertschnig: Acute GVHD reduces TRA display by FRC and induces loss of a critical peripheral tolerance mechanism that prevents expansion and pathogenicity of autoreactive T cells. #bmtsm #gvhdsm #GvHD European Hematology Association UCL

Work from my postdoc IIT pre-published Journal of Clinical Investigation How #GVHD impairs expression of self-antigens in #LN #stroma #FRC and promotes #autoimmunity doi.org/10.1172/JCI133…

Absolutely chuffed about Ivan Maillard's commentary on my recent paper in JCI! Look at this beautiful figure summarising my thymus and lymph node work from my PhD and postdoc...doi.org/10.1172/JCI136… #GVHD #thymus #lymphnode #FRC #immunetolerance #Tcells

After more than a year in review, the last paper from our time at IIT has finally been accepted, and I can't tell you how much I needed this boost to my morale! #BehindTheData will follow when it comes out in @immjournal. 🍾 will follow as soon as it's socially acceptable!

Let’s take a break from #COVID19 to go #BehindTheData on the new paper from Antonia Cuff, Simone Dertschnig and our friends at ImmunoPasteur, out now in @immjournal. A thread! onlinelibrary.wiley.com/doi/abs/10.111…

My dad just asked me how much money we get as a bonus per publication.....😅 Academic Chatter™ OpenAcademics

#Priothera closes €30 million Series A financing to develop highly promising therapies for acute myeloid leukemia #AML #HSCT #hematology #GVHD #GVL prnewswire.com/news-releases/…

This letter published today in the Lancet explains why #HerdImmunity will not work as a strategy against #COVID19. I will be adding my signature. thelancet.com/lancet/article…

Apply for an #EHAgrant to boost your research, it definitely did it to mine #YoungEHA #hematology #research

More than ever it is important to roll up your sleeves and get your flu jabs. We know it can be a little worrying so Dr Joe Grove from the IIT is here to tell us a little more about the process.

Ribosomes: getting the job done since 4 billion BC.

Not my usual Friday night (except the pizza maybe) #ASH2020 #ASHFromHome #hematology

Not everyone will see - or believe! - one woman's GoogleDoc. So I'd like to thank Nature Rev Immunol for inviting me to write this article about #COVID19 #vaccines, #fertility, #pregnancy and #breastfeeding... 💉🤰🏿🤱🏼

Priothera is looking for a #ClinicalScientist #hiring #HSCT #AML #clinicaltrials #clinicalresearch #GVHD linkedin.com/jobs/view/2594…

I'm looking for an Associate Researcher to join Priothera. If you have a #PhD and experience in #immunology and #haematology, get in touch! #hiring #research #basel #HSCT #alloBMT #AML linkedin.com/jobs/view/2596…

Graft-versus-host disease: a disorder of tissue regeneration and repair loom.ly/biH7BdU #GVHD

CONGRESS | #EHA2022 | Simone Dertschnig, Priothera SAS, presents the first-in-human results from S1P receptor mocravimod in patients undergoing allo-HSCT. Mocravimod was well-tolerated and survival data were encouraging. #gvhd

Positive data from Priothera's Phase 1b #clinicaltrial evaluating lead asset, #mocravimod in allogeneic hematopoietic cell transplantation (#HSCT) patients has been published in Transplantation and Cellular Therapy. Read the full publication in ASTCT: lnkd.in/eGfG3Dpp

First patients enrolled for Priothera’s mocravimod trial Treatment is a maintenance therapy for ... tinyurl.com/2zzovfwc tinyurl.com/2zzovfwc

CONGRESS|#EBMT23 Zixuan Zhang Hokkaido University presents how #Mocravimod ameliorates cGvHD in mice by significantly reducing CD4+ donor T-cells in lymphoid & #GvHD target organs while sparing CD8+ T cells in spleen, bone marrow & liver, thereby maintaining GVL effects. #bmtsm